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One of the primary characteristics of an immune response is the specificity of antigen 
recognition.  This  specificity  is  manifest  in  the  activities  of  both  thymus-derived 
lymphocytes (T cells) I and  bone marrow-derived lymphocytes (B  cells)  and  in  the 
antibody produced by the B cells (1-11). We have studied the specificity of the T cells 
that mediate the helper function in the response of mice to heterologous erythrocyte 
antigens and have observed that these cells  display a less  restricted specificity than 
the antierythrocyte antibody produced by B cells (12). 
Similar observations have recently been reported by others working with eryt]rro- 
cyte (13-15)  and  protein  ~ (16--18)  antigens; however, Rajewsky et al.,  using  heter- 
ologous serum albumin antigens, (19, 20)  failed to see any qualitative differences  be- 
tween the specificities  of helper T cells and of humoral antibody. 
A  shortcoming  in  several  of  the  relevant  studies  is  that  T  cells  were  not 
established  as limiting in the assay for their  activity and that therefore  exag- 
gerated cross-reactivities with other antigens might have been measured. In the 
present study we measure T  cell helper activity in the in vitro response of mouse 
spleen  cells  to  the  hapten  trinitrophenol  (TNP),  coupled  to  an  erythrocyte 
carrier, using a  titration  technique that assures that T  cell activity is the limit- 
ing component in the system. We confirm our previous observation of the less 
restricted specificity of T  cells compared with antibody and discuss the implica- 
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tions of this finding with respect to the sensitivity and regulation of the cellular 
and humoral immune  responses. 
Materials and Methods 
M/ce.--8-12-wk-old hybrid mice  (BDF1), raised in our own colony from C57BL/6 female 
X  DBA/2 male, were used in all experiments. 
Antigens.--Sheep erythlocytes  (SRBC)  from a  single animal  (no. 446)  and horse, goat, 
and  chicken erythrocytes  (HRBC,  GRBC,  and  CRBC,  respectively),  each pooled  from  a 
number  of  animals,  were  obtained  from  the  Colorado  Serum  Company  (Denver,  Colo.). 
Burro erythlocytes (BRBC)  from a  single animal (Maggie) were obtained from Davis Lab- 
oratories, Inc. (Davis, Calif.). Toads (Bufo marinus) from the Miami Pet Farm (Miami, Fla.) 
were the generous gift of Dr.  Stanley Mendoza. Erythrocytes  (TRBC)  were pooled tom  a 
number of toads. TNP-coupled erythrocytes were prepared by the method of Rittenberg and 
Pratt (21) as modified by Kettman and Dutton (22). In vivo immunizations were given inha- 
venously in 0.2  ml balanced salt solution  (BSS). In vitro inlmunizations were 0.05 ml of a 
0.2% suspension of erythrocytes (~-~2 X  108) per culture. 
C~dtures.--Spleen cell suspensions wele  cultured by  the method  of  Mishell and  Dutton 
(23), as modified by Kettman and Dutton  (22),  for the TNP-erythlocyte antigens. The cell 
concentration was 107 spleen cells per culture in all experiments. 
Antisera.--Primary  anti-SRBC sera were pooled from nine mice 5 days after a  primary 
immunization with 2  X  108 SRBC.  For secondary anti-SRBC serum, 50 mice were given a 
primary immunization with 2  ;<  107  SRBC,  followed  3--4 mo later with a  secondary im- 
munization with 2  )<  l0 s  SRBC.  The animals were  bled  5  days  later,  and  the sera were 
pooled. 
Hemagglutination  Titers.--Microhemagglutination  titers  were  obtained  in  disposable 
titration plates  (Cooke  Engineering Co.,  Alexandria, Va.),  25-#1  transfer loops being used. 
The diluant was BSS, and 25 #1 of a  1% suspension of erythrocytes were added to each well. 
Assay  of Antlbody-Producing Cells.--Cells producing  antibody  specific  for  erythrocyte 
determinants were  enumerated  by  the  Jelam hemolytic plaque  assay  (24),  as  modified  by 
Mishell and Dutton (23). IgM or "direct" plaques were developed with guinea pig complement 
alone. IgG or  "indirect" plaques were developed with guinea pig complement containing a 
1/200 dilution of rabbit antimouse IgG. 
TNP-specific  antibody-producing cells  were  assayed  by  the  method  of  Rittenberg  and 
Pratt (21)  as modified by Kettman and Dutton (22), using TNP coupled to HRBC. In each 
assay a  parallel determination was  made by assaying with TNP-free  HRBC.  This HRBC 
"background" was  subtracted from  the value obtained with TNP-HRBC  to  calculate  the 
number of  TNP-specific  plaque-fornfing cells  (PFC).  The  correction  seldom  amounted  to 
more than 10%. 
Assay of Thymus-Derived ttdper Cdls.--The  helper activity of T  cells  was assayed by a 
modification of the method of Kettman and Dutton  (6, 7, 22). Helpei  activity was equated 
with the ability of spleen cells from mice primed with a carrier erythrocyte to enhance the in 
vitro anti-TNP  response of normal spleen  cells  when presented  with TNP  coupled  to  the 
same or another carrier erythrocyte. The method is represented schematically in Fig.  1.  It 
is reasonable to assume that the immunization of mice with a carrier erythrocyte to increase 
the helper T  cell activity in the spleen has little or no effect on the concentration of TNP- 
specific precursors.  Therefore,  as  one  cultures  normal  spleen  cells  diluted  with  increasing 
numbers of cartier-primed spleen cells,  keeping the total cell number constant (represented 
on  the  abscissa),  the  concentration  of  TNP-specific  precursors  remains  constant in  each 
culture. However, since there is more T  cell activity in the primed cells than in the normal 
cells,  the concentration of helper T  cell activity in the cultures increases linearly with the 
dilution.  At the beginning of  the dilution, T  cell activity would  be limiting; but it is con- MICHAEL HOFFMANN AND  JOHN  W.  KAPPLER  723 
W 
0 
% ~1.5 
z 
a.  ~.o 
jO.5 
c,~  _J 
~"  uJ 
0 
o 
I-- 
bJ 
_j  .J 
W  b.I 
~  212 
0 
PRIMED 
NORMAL 
T  CELLS  T CELLS 
LiMiTING  IN EXCESS 
TNP- SPECIFIC PRECURSORS  ~ 
""  R 
,3Z-" 
I  I  I  I 
0  20  40  60  80 
I00  80  60  40  20 
PERCENT NORMAL OR  PRIMED 
SPLEEN  CELLS/CULTURE 
I00 
O 
FIG. i. Schematic representation of the technique for assaying helper T  cell activity. See 
text for explanation. 
ceivable that as the dilution proceeds, a point is reached at which the system becomes saturated 
with T  cell activity. Past this point T  cells would be in excess; and TNP-specific precursors 
would become limiting. If the anfi-TNP response of the cultures is linearly related to  the 
limiting component, then one would predict that the response would follow  the heavy line 
through the dilution. The relative increase in helper T cell activity that accompanies priming 
could be estimated from the initial slope of this titration curve. 
Fig. 2 shows an example of this dilution titration in which normal spleen cells and SRBC- 
primed spleen cells and TNP-SRBC as antigen are used. The anti-TNP response is plotted 
vs.  the number of carrier-primed spleen cells  per culture.  The anfi-TNP response of the 
normal cells was 337 PFC/106 recovered cells on day 4 of culture. As these cells were diluted 
with primed cells, the anti-TNP response rose llnear]y,  eventually reaching a peak at about 
1,050 PFC/106. At this point the cultures contained 15%, or 1.5 X  106, primed spleen cells. 
As the titration continued, the response plateaued as predicted. The initial slope  (first  four 
points) of the titration curve was taken as a measure of T  cell activity, the best straight line 
was fit to the data, and a slope of 461 anti-TNP PFC/106 recovered cells per 106 primed cells 
was calculated. 
At priming doses of below  approximately 106 SRBC, titration curves similar to those in 
Fig. 2 are obtained. At higher priming doses, one still obtains a linear initial slope; but rather 724  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
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Fro.  2.  Assay of helper  T  cell  activity  in  spleen  cells from  SRBC-primed  mice.  Three 
mice were injected with 2  X  10  5 SRBC  each. After 4  days, a  pooled  spleen cell suspension 
was prepared  from these and from normal mice.  Cultures were prepared  from various pro- 
portions  of primed  and  normal cells, keeping  the  total  cell  concentration  at  10  X  10  6 per 
culture. The cultures were immunized with TNP-SRBC  and, after 4  days, were assayed for 
TNP-specific  PFC,  pooling  four  cultuxes for  each  determination.  Results  are  repotted  as 
anti-TNP  PFC/10 6  recovered  spleen  cells. 
than a  sustained plateau, one observes that the anti-TNP response begins to fall off at high 
concentrations of carrier-primed spleen cells in the cultmes. The explanation for this effect is 
unclear. It may be due to some inhibitory component (introduced into the cultures with the 
primed spleen cells)  such as  (a)  anti-SRBC antibody,  (b)  too  many helper T  cells or  "sup- 
pressor" T  cells,  or  (c)  an expanded population  of SRBC-specific B  cell  precursors, which 
compete with  anti-TNP plecursors for  the  available T  cells.  In  any event, initial  titration 
slopes having proven  to be linear at all priming doses, routinely complete titrations  are not 
performed, but simply four to six concentlations of primed cells to determine the initial slope. 
And in the glaphic presentation of data,  for ease of comparison of several titrations plotted 
on the same axes, the ordinate scale is adjusted so that for each titration the ordinate inter- 
cept is zeio. Thus the ordinate axis records the enhancement of the anti-TNP response above 
that of normal cells alone. 
An example is given in Fig. 3, which shows a  series of titrations for mouse spleen cells that 
had been primed with different doses of SRBC,  titlated  against a  common pool of normal 
cells.  In  this example,  as  the priming dose  increased,  the  concentration  of  T  cell  activity 
increased, until a  maximum was reached at a dose of 1.6 X  106 SRBC. 
The technique can be used to assay helper T  cell activity with any of a  number of eryth- MICHAEL  HOFFMANN  AND  JOHN  W.  KAPPLER  725 
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Fzo. 3. Helper T  cell activity vs. priming dose of SRBC. Groups of three mice were primed 
with either 64 X  105  (e),  16 X  105 (I), 4  X  105 (&), or 1 X  105  (V)  SRBC. After 4 days, 
spleen cell suspensions were prepared  from each group and were fitrated  against a  common 
pool of normal ceils, as described in Fig. 2. The least squares method was used to fit the best 
straight line to the data,  and the ordinate intercept was adjusted to zero for each titration. 
The results are reported as the enhancement of the anti-TNP l esponse in anti-TNP PFC/106 
recovered cells vs. the number of primed spleen cells per culture. The slopes calculated from 
these data were 748, 744, 578, and 268, respectively, for priming doses of 64, 16, 4, and 1 X  105 
SRBC. 
rocyte  calriers.  The  data from five experiments are  plotted  in  Fig.  4.  Spleen  cells  from 
mice  that had  been immunized with a  particular carrier erythrocyte were  titrated  against 
normal spleen cells, TNP coupled to the same erythrocyte being used as antigen. In each case 
the anti-TNP response of the normal cultures was enhanced by the addition of carriel-primed 
cells,  showing that helper activity is limiting for each erythrocyte in the spleens of normal 
animals, but rises rapidly after priming. 
RESULTS 
The  specificity of anti-SRBC  antibody for SRBC  and  other  heterologous 
erythrocytes was determined by means of a  number of functional assays:  the 
ability of the antibody to agglutinate the erythrocytes in a microhemagglutina- 
tion assay,  the ability of the antibody to lyse the erythrocytes in a  hemolytic 
plaque  assay,  and  the  ability  of the  antibody  to suppress  a  primary in vitro 
immune response to the erythrocyte antigens or to the hapten TNP coupled to 
the erythrocytes as carriers. 726  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
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FIG. 4. Helper T  cell activity for various carrier erythrocytes. The results are flom five 
experiments. In each experiment a group of three mice  was immunized with an optimal dose 
of a particular  erythrocyte  carrier: BRBC  (A), GRBC  (t,  CRBC  (V),  SRBC (0)  and 
TRBC (0). After 4 days, a spleen cell suspension was prepared and titrated against normal 
cells, as described in Fig. 2, immunizing the cultures with TNP coupled to the same cartier 
erythrocyte.  Three  to four cultures were pooled for each determination. The data are pre- 
sented as in Fig. 3. Immunizing doses: 2 X  l0  s BRBC, 2 X  106 GRBC, 4 X  107 CRBC, 
2 X l0  T  SRBC, 2 X 106 TRBC. Calculation of the slopes of these titration lines yields values 
of 861,564, 350, 329, and 195 anti-TNP PFC/106 recovered cells per 106 primed cells, respec- 
tively, for the carriers BRBC, GRBC, CRBC, SRBC, and TRBC. 
The results of the hemagglutination assays are shown in Table I. Both pri- 
mary and secondary anti-SRB  C sera show a high degree of specificity for S RB C. 
Cross-reactivity with  GRBC  was  detected  in  the  secondary serum,  but  no 
cross-reactivity with the other erythrocytes was seen in either serum. 
Comparable results were obtained with  the hemolytic plaque assay  (Table 
II). After a primary in vivo immunization  with SRBC, IgM or direct PFC were 
detected in the  spleen with both SRBC  and GRBC,  but not with BRBC  or 
CRBC. Similarly, after a secondary immunization with SRBC, IgG or indirect 
PFC were observed with SRBC and GRBC, but not with BRBC or CRBC. MICHAEL HOFFMANN AND  JOHN" W.  KAPPLER 
TABLE  I 
Specificity  of Hemagglutination  by Primary and  Secondary  Anti-SRBC Serum 
727 
Antigen 
Hemagglutination titer (logs) 
Primary*  Secondary* 
SRBC  6.2  ~  0.6~  9.9  ~  1.9, 
GRBC  <1  3.8  ~  0.6 
BRBC  <1  <1 
CRBC  <1  <1 
TRBC  <1  <1 
* For preparation of sera, see Materials and Methods. 
:~ Average of three determinations; 95% confidence limits. 
TABLE  II 
Specificity  of In Vivo Anti-SRBC PFC 
Primary 
direct 
PFC 
Secondary 
indirect 
PFC 
:xp.  Mous 
no.  no, 
1  1 
2 
3 
4 
5 
6 
Av 
1 
2 
13 
~ Av 
1 
12 
3 
I  Av 
Antigen  used  in assay 
PFC/IO  6 
391 
438 
834 
492 
318 
227 
5950 
M70 
44~ 
3400 
3430 
3580 
SRBC  GRBC  BRBC  CRBC 
100 
~c 
100 
100 
100 
100 
100 
PFC/IO  6 
72 
93 
73 
38 
1440 
1210 
1480 
1820 
1210 
1650 
PFC/IO  6 
0.1 
1.9 
0.6 
0.2 
<0.1 
0.1 
1.1 
0.4 
0.9 
9.0 
7.9 
4.3 
% 
0.03 
0.43 
0.07 
0.04 
<0.03 
0.04 
0.11 
0.02 
0.01 
0.02 
0.02 
0.26 
0.23 
0.12 
0.20 
,FC/IO  s 
1.8 
0.7 
0.3 
0.9 
1.2 
0.4 
<0.4 
3.8 
<0.4 
<0.4 
0.4 
0.4 
% 
0.46 
0.16 
0.04 
0.18 
0.38 
0.18 
0.23 
<0.01 
0.06 
<0.01 
0.03 
<0.01 
0.01 
0.01 
0.01 
Exp.  1.  Six mice were immunized with 2  X  10 s SRBC. 4 days later, spleen cell suspen- 
sions were prepared and assayed for direct hemolytic PFC, various erythrocytes being used 
in the assay. Exps. 2 and 3. Three mice were immunized with 2 X  107 SRBC. 4 mo later, a 
secondary immunization with 2 X  10 s SRBC was given. 5 days later, spleen cell suspensions 
were prepared and assayed for indirect hemolytic PFC, various erythrocytes being used in 
the assay. Results are reported as PFC per 106 spleen cells and as the percent of the results 
obtained with SRBC in the assay. 728  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
TABLE III 
Specificity  of In  Vitro  Anti-SRBC PFC 
Normal  i  l 
,2 
i3 
4 
Av 
SRBC  1 
primed  2 
i 3 
Av 
i 
~"  SRBC 
6  Dif- 
+Ag  -Ag  fer  % 
,  ~  I  ence 
428  49  37~  100 
I 
433  39  [  39, 
c~ 
2,955  57  2,89t  " 
592  30  I  56:  " 
I 
10o 
11,281  528  0,751 100 
5,716  447  5,26!  " 
8,229  443  7,781  " 
100 
Antigen used in assay 
GRBC  BRBC  CRBC 
Dff- 
+Ag]-Ag  I  fer- 
ence 
36  2 
[  3s  54  16  9 
190  26  164  5 
61  22  39  6 
17 
2 945  6  3,140  394  2,746  13 
3,289  344  19 
3,281  228  31053 
I  ]16 
I 
1 
2 
3 
DiG 
fer- 
ence 
1  0 
1  0 
5  -3 
4  -1 
8  7 
4  --2 
1  2 
% 
0 
0 
-0.10 
-0.18 
-0.07 
0.03 
-0.Ol 
0.01 
0.01 
Dif- 
~Agl  -A  fer- 
ence 
35  29  6 
26  35  --11 
60  80  --20 
33  16  17 
42  61  --19 
21  22  --1 
115  74  41 
% 
1.6 
--2.8 
--0.7 
3.0 
O. 28 
--0.09 
--0.01 
0.23 
O. 04 
Spleen cells from normal mice or from mice immunized 4  days  previously with  2  X  10  z SRBC were  cultured  with 
(+ Ag) or without (-Ag) the addition of SRBC to the cultures. 4 days later, the cultured cells were assayed for direct he- 
molytic PFC, various erythrocytes being used in the  assay.  The  results  are  reported  as  PFC  per 10  ~ recovered spleen 
ceils. The SRBC-stimulated portion of the response was calculated  (Difference),  and is also reported  as  the  percent 
of the results obtained with SRBC in the assay. 
To assure that the specificity of the response to SRBC  was not different in 
vitro, the cross-reactivity of anti-SRBC PFC in cultures of normal and SRBC- 
primed spleen cells immunized with SRBC  was determined  (Table III). Since 
there is a spontaneous appearance of PFC specific for most erythrocytes in this 
culture system, in each case a parallel determination was made in cultures in 
which the SRBC antigen was omitted and the number of antigen-induced PFC 
was calculated. The results are for IgM or direct PFC only, since in our hands 
the  IgG response  is  poor  in  this  in  vitro  system.  Again,  considerable  cross- 
reactivity is seen with GRBC, but not with BRBC or CRBC. 
Finally,  the  ability of anti-SRBC  serum to  suppress a  primary in vitro re- 
sponse was determined, using the various erythrocytes as antigens themselves 
or  as  carriers  for  the  hapten  TNP.  The  results  are  presented  in  Table  IV. 
Anti-SRBC serum suppressed both the antierythrocyte and antihapten response 
when SRBC or GRBC were used as antigen or carrier, but not when BRBC or 
CRBC were used. 
With  this  pattern  of  cross-reactivity established  at  the  antibody level,  we 
determined the specificity at the level of SRBC-primed helper T  cells. Mice were 
primed with SRBC, and the ability of the SRBC-primed helper T  cells to help 
anti-TNP responses involving other carriers was determined. A  typical experi- 
ment is shown in Fig. 5. It can be seen that the SRB('-primed helper cells also 
are capable of enhancing the anti-TNP response when GRBC and, to a smaller MICHAEL HOFFMANN AND  JOHN W.  KAPPLER  729 
TABLE  IV 
Specificity  of the Suppression  of the In  Vitro Immune Response  by Anti-SRBC Serum 
Anti-SRBC 
Culture  immunogen  serum 
added 
In vitro immune response  (PFC/10 6 recovered spleen cells) 
Anti-SRBC  Anti-GRBC  Anti-BRBC  Anti-CRBC  Anti-TNP 
'INP-SRBC  --  3,881  --  --  --  193 
q-  43  53 
~1 NP-GRBC  --  --  1,046  --  --  447 
~-  11  64 
TN  P-B RB C  --  --  --  881  --  394 
q-  1,031  363 
rl NP-CRBC  ....  954  702 
+  753  713 
None  --  150  25  11  49  21 
+  67  6  1  51  53 
Cultures  of  spleen cells from normal  mice were immunized with either  TNP-SRBC, 
TNP-GRBC, TNP-BRBC,  TNP-CRBC,  or no immunogen in the presence or absence of 
3 #1 of secondary anti-SRBC  serum per culture. 4 days later,  the cultures were harvested 
and assayed for both  the antierythrocyte  and anti-TNP response. Results are reported as 
PFC per 106 recovered spleen cells. 
extent,  when BRBC  are  used  as  carrier.  No  significant enhancement is  seen 
with CRBC or TRBC as carrier. An estimation of the extent of cross-reactivity 
is calculated by comparing the slopes of the titration lines. In the experiment 
in Fig. 5, assuming 100% for the slope when SRBC is used as carrier, the slopes 
are 95,  18,  2,  and --5 when GRBC, BRBC, CRBC, and TRBC, respectively, 
are used as carrier. The summarized results of a number of similar experiments 
are  shown in Table V.  The antigenic similarities between SRBC  and GRBC 
detected at the antibody level were also seen at the helper-cell level, where they 
appear to be more extensive. The similarities between SRBC and BRBC were 
detected only at the helper-cell level. 
To see if this type of cross-reactivity is a property peculiar to SRBC-primed 
T  cells, reciprocal experiments were performed with BRBC and TRBC as the 
priming antigens. The results are presented in Figs. 6 and 7. TRBC-primed T 
cells cross-react significantly with none of the  tested carriers, whereas,  as ex- 
pected,  BRBC-primed T  cells cross-react with SRBC  (~15 %),  but not with 
CRBC or TRBC. 
DISCUSSION 
We have examined the specificity of both the helper T  cells and the antibody 
produced in the response of mice to  a  series of heterologous erythrocytes. In 
determining the  antigen specificity of  the  antibody produced  in response  to 
SRBC,  we  selected  as  additional test  antigens erythrocytes from  the  closely 
related  species  goat  and  from  the  progressively more  distant  species  burro, 
chicken, and toad. The specificity was determined by a  number of functional ...  i,ooo 
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FIC.  5. Specificity of SRBC-primed helper T  cell  activity. Spleen ceils pooled from three 
mice that had been primed 4 days previously with 2  X  106 SRBC were added in increasing 
numbers to cultures of normal spleen cells,  keeping the total cell  concentration at  107 per 
culture. Cultures were then immunized with either TNP-SRBC, TNP-GRBC, TNP-BRBC, 
TNP-CRBC,  or  TNP-TRBC.  After 4  days  the  anti-TNP  responses of  the cultures were 
assayed by the hemolytic plaque assay. The influence of the SRBC-primed spleen cells on 
the anti-TNP response of the normal cells is plotted as the enhancement of the anti-TNP 
response above the normal response (PFC/10  ~ recovered cells)  vs.  the number of SRBC- 
primed spleen cells per culture. The TNP erythrocyte carrier is indicated for each titration, 
and the best straight line is fit to the data. The anti-TNP responses (PFC per 106 recovered 
cells)  of normal spleen cells  alone with  the  respective carriets were:  SRBC,  118; GRBC, 
122;  BRBC,  132; CRBC,  68;  TRBC,  221. The  helper activities with each of  the carriers 
cMculated  from the slope of the titrations (PFC per 106 recovered cells per 106 primed cells) 
were: SRBC, 799; GRBC, 759; BRBC,  148; CRBC, 4; TRBC,  --16. 
TABLE  V 
Summary of the Specificity of SRBC-Primed Helper T  Cell Activity 
In vitro  TNP  carrier 
GRBC  BRBC  CRBC  TRBC 
Average percent cross-reactivity  113  29  2.4  0.0 
with SRBC 
No. of determinations  6  13  6  5 
Range  82-159  2-67  -- 2-5  --2  2 
Standard deviation  4-26  4-18  4-3.7  4-1.6 
The protocol for each experiment was as in Fig. 5. The SRBC-priming dose varied from 
106  to  l07.  The slopes of titration curves were calculated, and cross-reactivity with SRBC 
was estimated as described in the text. 
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FIG. 6.  Specificity of BRBC-primed helper T  cell activity. The experimental protocol is 
the same as in Fig. 5, except that the priming immunogen was 2 X  106 BRBC and the culture 
immunogens were TNP-BRBC, TNP-SRBC, TNP-CRBC, and TNP-TRBC. The anti-TNP 
responses  (PFC  per  106  recovered  cells)  of normal spleen  cells alone  with  the  respective 
carriers were: BRBC, 360; SRBC,  216; CRBC,  357; TRBC, 274. The helper activities with 
each of the carriers calculated from  the slope of the titration lines  (PFC per 106 recovered 
cell per 106 primed cells) were: BRBC, 620; SRBC, 83; CRBC,  6; TRBC, --7. 
assays: the  ability to  agglutinate antigen,  the ability to  cause hemolysis, and 
the ability to suppress the immune response. Whereas anti-SRBC antibody was 
demonstrated to cross-react with GRBC  at all the levels tested, no cross-reac- 
tivity was  seen  with  BRBC,  CRBC,  or TRBC.  These findings are consistent 
with previous reports in the literature (1,  2, 23). 
To  determine the specificity of the helper T  cells that  appear in  the spleen 
after  immunization  with  SRBC,  the  ability of  these  SRBC-primed  helper T 
cells to enhance an in vitro anti-TNP response was measured, using the various 
test erythrocytes as carrier for the TNP. In each case titrations were performed 
to assure that T  cell activity was assayed when  limiting. 732  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
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FIG. 7.  Specificity of TRBC-primed helper T  cell activity. The experimental protocol is 
the same in Fig. 5, except that the printing immunogen was 2 X  106 TRBC and the culture 
immunogens were TNP-TRBC, TNP-SRBC, TNP-BRBC, and TNP-GRBC. The anti-TNP 
responses  (PFC per 106 recovered cells) of the normal spleen cells alone with the respective 
carriers were: TRBC,  114; SRBC, 25; BRBC, 72; GRBC,  72. The helper activity with each 
of the carriers calculated from the slope of the titrations (PFC per 106 recovered cells per l0  G 
primed cells) were: TRBC, 167; SRBC, 3; BRBC,  --2; GRBC, 3. 
The  results  (Fig.  5,  Table V)  show  that  SRBC-primed  T  ceils cross-react 
with GRBC; however, the degree of cross-reaction (> 100 %) is higher than that 
seen  at  the  antibody level  (6-50%).  A  significant cross-reactivity is also ob- 
served  with  BRBC  (~-~30%),  although  no  significant  cross-reactivity is  seen 
with this erythrocyte at the antibody level (<0.20 %). That  this enhancement 
of the anti-TNP  response is not due to some general nonspecific stimulus pro- 
duced by the  SRBC-primed cells is shown by the lack of significant enhance- 
ment when  either CRBC  or TRBC  are used as the TNP  carrier. 
The  antigenic similarity between SRBC  and BRBC  was also demonstrated 
in a  reciprocal experiment in which  spleen cells from mice that  had been  ira- MICHAEL  HOFFMANN  AND  JOHN  W.  KAPPLER  733 
munized with BRBC were titrated against normal cells using BRBC, SRBC, 
CRBC, or TRBC as TNP carriers (Fig. 6). As predicted on the basis of the 
preceding experiment, these helper T  cells cross-reacted with SRBC (~-~15  %), 
but  not  with  CRBC  or TRBC.  In  a  control  experiment,  the  specificity of 
TRBC-primed  T  cells  was  tested  with  TRBC,  GRBC,  SRBC,  and  BRBC 
(Fig. 7). There was no cross-reactivity with the other erythrocytes. 
These data  confirm and  quantitate  our preliminary findings  on  the  cross- 
reactivity of SRBC-primed helper cells with GRBC and BRBC (12). Recently 
others working with erythrocyte antigens have reported similar results.  Cun- 
ningham and Sercarz (13), working in a  transfer system in mice, have found 
that helper T  cells primed by cow erythrocytes can also help in the response 
to SRBC and HRBC and that the extent of this cross-reaction is greater than 
that  seen  at  the  PFC  level. Playfair  (14)  has  recently reported  that  radio- 
resistant  helper  T  cells  induced  by priming  with  a  number  of  mammalian 
erythrocytes (rabbit,  pig,  human,  horse)  could  help  the  response  of irradi- 
ated,  bone  marrow-restored  recipients  to  SRBC.  Haritou  and  Argyris  (15), 
using a rosette assay, have shown considerable cross-reactivity between SRBC 
and HRBC  at  the T  cell  level, whereas  these antigens  do not cross-react at 
the PFC level. 
Rajewsky et al.  (19,  20)  have studied the specificity of the helper cells in- 
volved in  the  response of mice  to  the  hapten  4-hydroxy-5-iodo-3-nitrophen- 
acetate  (NIP)  coupled  to  either  sheep  or  bovine  serum  albumin  as  carrier. 
Although they conclude that the extent of cross-reactivity of the helper T  cells 
for these two antigens closely follows the extent of cross-reactivity seen at the 
serum  antibody  level,  several  other  workers  have  recently reported  differ- 
ences between T cells and B cells in the recognition of protein antigens. Thomp- 
son et al.  (16)  have demonstrated that antibodies produced in guinea pigs to 
the  antigens,  lysozyme,  and  reduced,  carboxymethylated lysozyme  do  not 
cross-react,  whereas  extensive cross-reactivity is  seen  at  the  level of T  cell- 
mediated, delayed hypersensitivity. Similar experiments have been performed 
by Parish (17), using bacterial flagellin and acetylated flagellin in rats, and by 
Cooper (18), using, in mice, flagella from two strains of Salmonella  that show 
no  serological  cross-reactivity.  Ruben  and  Chiller"  have  shown  that  human 
gamma globulin (HGG) is capable of inducing unresponsiveness at the T  cell 
level, but not at the B cell level, to both bovine and horse gamma globulin. 
Several  of  these  studies  and  our  own  previous  findings  suffer  from  the 
shortcoming  that  the  assay  of  T  cell  activity  involves  a  method  in  which 
this activity may not always be limiting and that therefore exaggerated cross- 
reactivities  may  be  measured.  In  the  experiments  reported  here,  the  per- 
formance of titrations,  which  allowed  greater confidence in  the  quantitation 
of the assay, established that the helper T  cell activity was limiting. 
The basis  of the  apparently broader specificity range of helper cells com- 
pared with antibody is as yet unexplained. Several possibilities exist. 734  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
Some T  cells may be nonspecific or may each carry a number of specificities. 
This possibility seems unlikely in view of the lack of cross-reactivity of SRBC- 
primed T  cells with CRBC or TRBC. 
It may be that the receptors on T  cells are different from those on B  cells, 
which  would  result  in  the  two  populations'  "seeing" different determinants 
on the antigen. The T  cell receptor may be a  special class of Ig that does not 
appear in the humoral antibody, or it may be another type of molecule alto- 
gether. In the case of SRBC and BRBC, the cross-reaction of the T  cell could 
then be mediated by a determinant, or determinants, that does not participate 
in  the production of humoral  antibody. Although  this  is  a  troublesome posi- 
tion  to  defend on  theoretical grounds,  there  is  some  evidence to  support  it. 
There  is  a  considerable  body  of  evidence  documenting  the  existence  of 
immunoglobulin receptors on B  cells;  however, there is still controversy about 
the nature of the receptor on T  cells.  There are reports of failure to directly 
demonstrate Ig on the surface of T  cells with anti-Ig reagents (25-28), although 
others have been successful (29, 30). There are conflicting reports on the ability 
to  detect  surface  Ig  with  a  radioiodine  labeling  technique  (31-34).  On  the 
other  hand,  several  indirect  methods  have  indicated  the  presence  of  func- 
tional Ig receptors on T  cells. Lesley et al. (35)  have shown that helper T  cells 
can  be  killed  by  treatment  with  antikappa  serum  and  complement.  Also, 
Greaves and Hogg (36, 37) have demonstrated the inhibition of rosette forma- 
tion by T  cells with anti-Ig reagents. Mason and Warner  (38)  have inhibited 
cells  that  mediate  transplantation  immunity  and  delayed  hypersensitivity 
with anti-Ig reagents. 
Other evidence suggesting  the T  cell  receptors  mav differ  from B  cell re- 
ceptors is  the  reported  existence of  antigenic  determinants  that  are  specific 
for either T  cells or B  cells,  for example, those of glucagon  (39)  and enceph- 
alomyelitic protein (40).  The genetically controlled lesions in  the response of 
some  mice  to  the  synthetic  polypeptide  poly-e(Tyr,Glu)-poly-D,L-Ala-- 
poly-L-Lys [(T, G)-A--L] could be due to the absence of T  cells with specificity 
for  the  antigen  since  a  perfectly normal  anti-(T,G)-A--L antibody response 
can  be  elicited  in  these  mice  if  the  (T,G)-A--L is  coupled to  immunogenic 
carriers (41, 42). 
The  above  evidence  suggests  that  our  observation  of  the  less-restricted 
specificity of helper T  cells compared with  antibody may be explained by a 
basic difference in  the  receptors of T  cells and  B  cells.  However, our results 
are also compatible with the assumption  that the receptors on T  cells and B 
cells are  the same,  the differences being explained on the basis  of sensitivity 
rather than specificity. 
This  difference in  sensitivity may be  at  the  level of  antigen  stimulation. 
For instance,  the  stimulation of B  cells  may be restricted to cells with rela- 
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broader range of affinity and  therefore cross-react with other antigens in  the 
low-affinity range where B cells are not stimulated. 
The difference in sensitivity of T  cells and B  cells  to antigenic stimulus  has 
been shown by a  number of workers. Parish has demonstrated an inverse re- 
lationship between humoral antibody production and cellular immunity when 
a flagellin antigen is chemically modified by acetylation. He suggests that the 
effect is explained by a lower affinity requirement for the stimulation of T  cells 
than for B cells (17). 
Falkoff and Kettman (43)  have shown in this TNP-erythrocyte system that 
helper T  cells are stimulated by very low doses of antigen, which fail to stimu- 
late B  cells.  This selective stimulation of T  cells  by low doses of antigen has 
been demonstrated  by others  (44-46).  In  addition,  studies  have shown  that 
tolerance is  induced in  T  cells by much lower doses of antigen  than  are  re- 
quired for B cells (47, 48). 
Finally, we nmst consider the possibility that  the differences in sensitivity 
of T  cells and B cells might be at the level of the mediation of function rather 
than at the level of stimulation. The affinity of the antibody required for the 
agglutination  or lysis of antigen  or  the  suppression  of  the immune response 
may be considerably higher than that required by the receptors that  mediate 
T  cell  functions.  Therefore,  the  different  phenomena  may  show  different 
patterns  of  cross-reactivity,  even  though  they  are  mediated  by  identical 
molecules. 
Although  we  cannot  distinguish  among  the  possible  explanations  for  our 
findings,  discussed above, we have established  that  the T  cells that mediate 
the helper function for erythrocyte antigens display a  broader range of speci- 
ficity than does the antibody produced in a  humoral response. The biological 
significance of our findings is  substantiated  by the  observation by Kettman 
(49)  that the cells that mediate delayed hypersensitivity to these erythrocyte 
antigens in vivo show the same broad range of specificity as  the helper cells. 
This  differential activity of  SRBC-primed  T  cells  and  anti-SRBC  antibody 
with BRBC provides a  useful system for separating the cellular and humoral 
immune responses. 
Our findings and those of others discussed above suggest that the response 
of T  cells is extremely sensitive, but of rather broad specificity. From a  tele- 
ological point  of view  this  allows  the  animal  to  become easily sensitized  or 
"primed"  to  a  wide  range  of  environmental  antigens.  The  B  cell  response, 
on the other hand, may be reserved for a  more substantial  contact with anti- 
gen, e.g.  during a  bacterial infection, showing a  narrower specificity in order 
to deal with a specific antigen during a crisis.  These findings also suggest that, 
by proper manipulation or selection of antigen, one can selectively stimulate 
a cellular immune response in the absence of a humoral response, thus provid- 
ing  a  tool  that  may prove useful  in  situations  in  which  the  production  of 736  ANTIGEN  RECOGNITION  BY  T  CELLS  AND  B  CELLS 
humoral "blocking" antibody interferes with the successful rejection of a tumor 
by cytotoxic T  cells (50). 
SUMMARY 
The  specificity  of  antigen  recognition  by  thymus-derived  helper  cells  (T 
cells)  and  antibody was examined in mice, heterologous erythrocyte antigens 
from  sheep  (SRBC),  goat  (GRBC),  burro  (BRBC),  chicken  (CRBC),  and 
toad  (TRBC)  being  used.  Antibody  specificity  was  tested  by  a  number  of 
functional  assays:  hemagglutination,  hemolysis,  and  immune  suppression. 
The specificity of T  cells was determined by titrating their ability to help the 
in  vitro  antitrinitrophenol  (TNP)  responses  of  mouse  spleen  cultures  im- 
munized with  the  hapten  coupled  to  the various test  erythrocytes as carrier. 
Anti-SRBC  antibody cross-reacted with GRBC, but not with BRBC,  CRBC, 
or TRBC.  In  contrast,  SRBC-primed helper T  cells cross-reacted with both 
GRBC  and BRBC,  but not with CRBC  or TRBC,  indicating  a  difference in 
the  specificity  of  antigen  recognition  between  the  cellular  and  the  humoral 
immune responses. 
This work was performed in the laboratory of Dr. R. W. Dutton, to whom we are grateful 
for advice and support. We also thank Sai a Albanil for her expert technical assistance. 
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